Gil Bashe

Who Will Pay for Prescription #Drugs in 2032: Four Takeaways from the New Government Forecasts DCI's analysis of the latest Centers for Medicare & Medicaid Services projections ==> https://drugch.nl/3xX6QQM

72

12 Comments

Many innovative ideas can become obscured when communicated, which was a significant challenge for Patient Blood Management #PBM as it was introduced to benefit those suffering from #anemia, in hopes of enabling surgery without the use of donated blood upon leaving the ER (Emergency Room). The PBM educational approach supports bloodless surgical procedures. To reduce this obscurity, we are simplifying the message and increasing awareness, benefiting #researchers, manufacturers, and healthcare practitioners. Most importantly, we are enhancing the patient experience and raising public awareness. We are confident that many global organizations, healthcare providers, and blood management surgical equipment manufacturers will support our efforts as we continue to be pioneers in building a bridge of engagement for public access, which will benefit this field of medicine. Remember our medical icons, just in case one day you need direction to the OR. #Bloodlines #BBTS #Blood #SABM

5

💡Great story, Jameson Fleming! Companies in the healthcare space stand to gain immensely by partnering with specialized agencies. It is crucial for public relations and corporate communications support. An agency should have expertise and an understanding of the application of emerging technologies like AI and machine learning in healthcare, as well as navigating the complexities of consumer privacy laws and other evolving regulations. Agencies that combine therapeutic knowledge with technological innovation and regulatory insight will undoubtedly drive better outcomes for their clients and the patients they serve.

5

Patient Blood Management #pbm is leading a global revolution in anemia care, uniting a diverse network of organizations, medical centers, and advocates. As the premier strategy for addressing iron deficiency, PBM has become essential in the fight against anemia. The challenge is demonstrating a collective commitment to this cause. Success in this battle relies not on individual voices but on presenting a unified front. Just as wars are won by clearly recognized and united armies, not by isolated teams, success depends on showing that everyone involved is fighting the same war. To this end, the #Anemia Emblem is introduced—a symbol of the shared mission and a clear sign of unity in this effort. This emblem represents true global innovation and growth, serving as a powerful, global identifier that showcases to patients, healthcare providers, and the public the unified dedication to managing anemia through PBM. Each time the Anemia Emblem is seen, it reinforces the joint effort and underscores the importance of PBM in improving anemia care worldwide. Just as the NO BLOOD emblem has long symbolized patients' preferences, the Anemia Emblem will become a recognized mark of collective commitment to battling anemia. By uniting under this emblem, the resolve is strengthened, demonstrating that together, a significant difference is being made. Time is not on our side in this battle. The sooner the recognition, the sooner the momentum will occur in saving the lives of others and managing the use of patients' blood.

3

Medical affairs communications programs are evolving, and a holistic approach to providing personalized educational and scientific content is critical to sustaining valuable relationship with stakeholder audiences. Read our latest white paper to learn how Lumanity’s Omnichannel Network Engagement Experience (ONEE) optimizes insights, content and technology and help medical affairs teams strengthen relationships and unlock the full potential of their communications program. Our multi-disciplinary team of omnichannel experts explore the benefits of, as well as the unique considerations and skills required to ensure success. Learn more about how we can help you develop and implement your omnichannel strategy and plan, and read the full white paper at https://buff.ly/49MKdvn #omnichannel #medicalaffairs #medicalcommunications #omnichannelstrategy #medaffairs #strategy

8

How do we advance #healthequity? Check out Taft’s latest #newsletter where we highlight some of our recent work with RWJF, Sanofi, and more. Read more: https://lnkd.in/e6sYzs_U  #PR #communications

7

1 Comment

Worth reading: Avalere explains how a #340B rebate model could resolve duplicate discounts with #IRA MFPs. Good overview of complexities and industry challenges. But will #hospitals allow problem to be solved? ==> https://drugch.nl/3ZeG4il

138

3 Comments

Today, we’re talking about transparency in Health Technology Assessment (HTA) and why it’s essential for healthcare. Transparency: ✔️ Builds trust between patients, providers, and policymakers. ✔️ Engages stakeholders for better decisions. ✔️ Ensures accountability for improved outcomes. Share your thoughts in the comments! And remember, BioXplore is here to support your HTA and market access strategies. 🔍 Listen here: https://lnkd.in/eTeM9sVD #HealthcareInnovation #HTA #HealthTech #TransparencyInHealthcare #PatientCare #MarketAccess #MedicalInnovation #HealthcareTrust #BioXplore #HealthEquity #StakeholderEngagement #HealthcareSolutions

8

Paul Shields, DO, CEO & CMO of GLIN IPA, recently attended the Centers for Medicare & Medicaid Services (CMS) Conference, making a significant impact as a panelist during the Health Equity in Action Session, as he discussed how GLIN IPA has implemented and operationalized support for patients in underserved communities. Dr. Shields emphasized the importance of collaboration, working with other ACOs to improve health equity outcomes nationwide. He stated, "I’m here to share our lessons learned and would love to meet with these groups again in the near future to discuss our successes with CMS programs." GLIN IPA is committed to revolutionizing healthcare in Western New York as a clinically integrated network (CIN). Kristin Cortese, LSS BB, GLIN IPA vice president of population health, and Katie Palumbo, MHA, GLIN IPA director of strategic programming, presented a poster on the "3-Day Waiver Medicare Waiver Benefit Enhancement Implementation." This initiative harmonized communication across five Electronic Health Record (EHR) platforms, ensuring consistent messaging and user-friendly engagement for staff while streamlining patient eligibility verification within our Accountable Care Organization (ACO) population health team. The focus was on patients admitted to network hospitals and primary care network physician practices. The primary objective of the Medicare Waiver Benefit Enhancement (BE) Implementation initiative was to enhance patient engagement and ensure equitable access to care while reducing healthcare costs. We implemented a Medicare waiver tracker to monitor utilization and actively engaged with partnered facilities to track key metrics like length of stay and outcomes. Overall, the CMS conference successfully showcased GLIN IPA's innovative approaches and commitment to improving healthcare delivery, highlighting our dedication to health equity and better patient care in underserved communities.

56

In this CDO Magazine podcast, Dr. Stuart Knechtle, Professor of Surgery at Duke University School of Medicine, speaks with Dr. Anthony Cristillo, PhD, MBA, MS, Digital Health Partner at Guidehouse, in a video interview about the meaning of data-driven culture in the field of transplantation, the possibilities unlocked by data interoperability, and addressing the challenges associated with disparate data sources. Watch the full interview: https://lnkd.in/eYBHnhvf   Guidehouse Health | #Healthcare #BigData #DataManagement

8

Decoding payer perspectives can be challenging. At ISPOR this year, Ben Penley, Manager of Evidence Generation & Value Communications, presented on payer willingness to pay for novel value attributes and the impact of higher willingness to pay thresholds on ICER's cost-effectiveness determinations. Here are key insights from his presentation ⬇️ https://ow.ly/ofGp50SxbMz

32

GI Partners has acquired a majority stake in eClinical Solutions, a key player in digital clinical software and services, to bolster its AI-powered data products and biometric services. This strategic move cements eClinical’s status as a trusted ally for pharmaceutical firms navigating complex trials and driving research advancements. Established in 2012, eClinical has been at the forefront of addressing clinical data challenges. Its elluminate Clinical Data Cloud® platform streamlines data processes, reduces cycle times, and boosts efficiency, positioning clinical trials for future success. Serving 16 of the top 50 biopharmaceutical companies, eClinical leverages its platform to unlock crucial data insights. Raj Indupuri, CEO of eClinical, underscores the company’s commitment to providing clients with a data and analytics infrastructure that expedites treatment delivery to patients. Bob Arnesen, President of eClinical, praises GI Partners’ expertise in scaling biopharmaceutical tech businesses and their market acumen, expecting the partnership to drive value for clients and partners. David Kreter, Managing Director at GI Partners, acknowledges eClinical's exceptional business and platform, emphasizing its role in facilitating informed decision-making and fostering biopharma innovation. GI Partners' investment will propel eClinical towards expanding its product offerings and enhancing its AI capabilities, ensuring cutting-edge clinical trials in the future. Read more: https://lnkd.in/dh28WYwJ Rachel Lowrey Christopher Dapolite Raj Indupuri

4

Join us for a brief and informative webinar dissecting the spectrum of payer value communications and illustrating the opportunity—and the need—to develop effective value communications with evolving payer narratives. During this presentation, Jamie Van Iderstine and Steven Serafin, PharmD, MBA, will highlight: - How evolving payer expectations for evidence and value can impact market access strategy - The impact of the quality of a value narrative on payer uptake and brand success - The building blocks for excellence in value narratives Register at https://buff.ly/4hqHfSb #MarketAccess #Payers #ValueCommunications #PayerNarratives #MarketAccessStrategy #ValueNarratives

4

🌟 News Updates that Follow the #Trends 🌟 December 25, 2024 -- Today’s top stories: 1.    💊 Digital Health Faces Wall Street Reckoning 2024 has been a tough year for digital health companies, with two-thirds of public firms seeing declines and others shuttering entirely. Once-dominant players like Teladoc Health are down 58%, showing how the sector is adjusting to post-COVID realities. 📉💡 2.    📈 #Turkey Hikes Minimum Wage by 30% Turkish President Erdogan announced a 30% increase in the 2025 minimum wage, now set at 22,104 lira (~$630). While this impacts 9 million workers, economists warn of inflationary pressures ahead. 🇹🇷💵 3.    🚀 #China SOEs Invest $274B in Emerging Industries China’s state-owned enterprises have poured CNY2 trillion ($274 billion) into #strategic emerging industries in the first 11 months of 2024, marking an 18.7% YOY increase. Key areas include #AI, #aerospace, and #quantum technology. 🇨🇳🔬 ✨ Stay informed and inspired with our daily updates! 🌐📜 Read: https://pse.is/6vukqj

5

1 Comment

🎬 Explore the transformative impact of Health Technology Assessment (HTA) in the United States and Canada. Understand how the Institute for Clinical and Economic Review (ICER) and the Canadian Agency for Drugs and Technologies in Health (CADTH) have revolutionized HTA by emphasizing cost-effectiveness, patient-centered care, and evidence-based decision-making. Gain insights into how their achievements can guide the future of healthcare innovation in Latin America. Presented by BioXplore, dedicated to enhancing healthcare quality and accessibility across the region. Let BioXplore assist you in developing market access strategies, ensuring your innovations reach those in need. #HTA #HealthcareInnovation #BioXplore #MarketAccess #DigitalHealth #PatientCenteredCare #CostEffectiveness #HealthcareQuality #LatinAmericaHealth #ICER #CADTH #HealthcareStrategy

20

HTA evaluates the value of medical technologies, but too often, patient perspectives are left out of the process. Including patient input ensures decisions reflect their needs, leading to better outcomes and greater health equity. Explore how Patient-Centered HTA is shaping a more inclusive healthcare system in this blog by Xanthia Lam, MPH candidate at Columbia University and Center Patient Engagement Intern: https://ow.ly/oTZe50UBybT #HealthEquity #PatientEngagement #HTA #HealthcareInnovation

4